<VariationArchive VariationID="1341380" VariationName="NM_000195.5(HPS1):c.962del (p.Gly321fs)" VariationType="Deletion" Accession="VCV001341380" Version="5" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2022-02-13" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="33962" VariationID="1341380">
      <GeneList>
        <Gene Symbol="HPS1" FullName="HPS1 biogenesis of lysosomal organelles complex 3 subunit 1" GeneID="3257" HGNC_ID="HGNC:5163" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="98413948" stop="98446935" display_start="98413948" display_stop="98446935" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="100175954" stop="100206703" display_start="100175954" display_stop="100206703" Strand="-" />
          </Location>
          <OMIM>604982</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000195.5(HPS1):c.962del (p.Gly321fs)</Name>
      <CanonicalSPDI>NC_000010.11:98427239:CCCCCC:CCCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10q24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="98427240" stop="98427240" display_start="98427240" display_stop="98427240" variantLength="1" positionVCF="98427239" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="100186997" stop="100186997" display_start="100186997" display_stop="100186997" variantLength="1" positionVCF="100186996" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>NM_000195.5(HPS1):c.962del</Name>
        <Name>p.Gly321fs</Name>
      </OtherNameList>
      <ProteinChange>G165fs</ProteinChange>
      <ProteinChange>G198fs</ProteinChange>
      <ProteinChange>G201fs</ProteinChange>
      <ProteinChange>G234fs</ProteinChange>
      <ProteinChange>G288fs</ProteinChange>
      <ProteinChange>G321fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.100187002del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.100187002del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.98427245del" Assembly="GRCh38">
            <Expression>NC_000010.11:g.98427245del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009646.1" sequenceAccession="NG_009646" sequenceVersion="1" change="g.24708del">
            <Expression>NG_009646.1:g.24708del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000195.5" sequenceAccession="NM_000195" sequenceVersion="5" change="c.962del" MANESelect="true">
            <Expression>NM_000195.5:c.962del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000186.2" sequenceAccession="NP_000186" sequenceVersion="2" change="p.Gly321fs">
            <Expression>NP_000186.2:p.Gly321fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001311345.2" sequenceAccession="NM_001311345" sequenceVersion="2" change="c.-11del">
            <Expression>NM_001311345.2:c.-11del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322476.2" sequenceAccession="NM_001322476" sequenceVersion="2" change="c.962del">
            <Expression>NM_001322476.2:c.962del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309405.1" sequenceAccession="NP_001309405" sequenceVersion="1" change="p.Gly321fs">
            <Expression>NP_001309405.1:p.Gly321fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322477.2" sequenceAccession="NM_001322477" sequenceVersion="2" change="c.962del">
            <Expression>NM_001322477.2:c.962del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309406.1" sequenceAccession="NP_001309406" sequenceVersion="1" change="p.Gly321fs">
            <Expression>NP_001309406.1:p.Gly321fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322478.2" sequenceAccession="NM_001322478" sequenceVersion="2" change="c.863del">
            <Expression>NM_001322478.2:c.863del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309407.1" sequenceAccession="NP_001309407" sequenceVersion="1" change="p.Gly288fs">
            <Expression>NP_001309407.1:p.Gly288fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322479.2" sequenceAccession="NM_001322479" sequenceVersion="2" change="c.863del">
            <Expression>NM_001322479.2:c.863del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309408.1" sequenceAccession="NP_001309408" sequenceVersion="1" change="p.Gly288fs">
            <Expression>NP_001309408.1:p.Gly288fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322480.2" sequenceAccession="NM_001322480" sequenceVersion="2" change="c.701del">
            <Expression>NM_001322480.2:c.701del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309409.1" sequenceAccession="NP_001309409" sequenceVersion="1" change="p.Gly234fs">
            <Expression>NP_001309409.1:p.Gly234fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322481.2" sequenceAccession="NM_001322481" sequenceVersion="2" change="c.701del">
            <Expression>NM_001322481.2:c.701del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309410.1" sequenceAccession="NP_001309410" sequenceVersion="1" change="p.Gly234fs">
            <Expression>NP_001309410.1:p.Gly234fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322482.2" sequenceAccession="NM_001322482" sequenceVersion="2" change="c.602del">
            <Expression>NM_001322482.2:c.602del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309411.1" sequenceAccession="NP_001309411" sequenceVersion="1" change="p.Gly201fs">
            <Expression>NP_001309411.1:p.Gly201fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322483.2" sequenceAccession="NM_001322483" sequenceVersion="2" change="c.593del">
            <Expression>NM_001322483.2:c.593del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309412.1" sequenceAccession="NP_001309412" sequenceVersion="1" change="p.Gly198fs">
            <Expression>NP_001309412.1:p.Gly198fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322484.2" sequenceAccession="NM_001322484" sequenceVersion="2" change="c.593del">
            <Expression>NM_001322484.2:c.593del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309413.1" sequenceAccession="NP_001309413" sequenceVersion="1" change="p.Gly198fs">
            <Expression>NP_001309413.1:p.Gly198fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322485.2" sequenceAccession="NM_001322485" sequenceVersion="2" change="c.494del">
            <Expression>NM_001322485.2:c.494del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309414.1" sequenceAccession="NP_001309414" sequenceVersion="1" change="p.Gly165fs">
            <Expression>NP_001309414.1:p.Gly165fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322487.2" sequenceAccession="NM_001322487" sequenceVersion="2" change="c.-11del">
            <Expression>NM_001322487.2:c.-11del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322489.2" sequenceAccession="NM_001322489" sequenceVersion="2" change="c.-11del">
            <Expression>NM_001322489.2:c.-11del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_562" sequenceAccession="LRG_562">
            <Expression>LRG_562:g.24708del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_562t1" sequenceAccession="LRG_562t1">
            <Expression>LRG_562t1:c.962del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_562p1" sequenceAccession="LRG_562p1" change="p.Gly321fs">
            <Expression>LRG_562p1:p.Gly321fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="281865081" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000195.5(HPS1):c.962del (p.Gly321fs) AND Hermansky-Pudlak syndrome" Accession="RCV001829294" Version="3">
        <ClassifiedConditionList TraitSetID="6264">
          <ClassifiedCondition DB="MedGen" ID="C0079504">Hermansky-Pudlak syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-11-29" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000195.5(HPS1):c.962del (p.Gly321fs) AND not provided" Accession="RCV002034692" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000195.5(HPS1):c.962del (p.Gly321fs) AND Hermansky-Pudlak syndrome 1" Accession="RCV003475105" Version="1">
        <ClassifiedConditionList TraitSetID="1465">
          <ClassifiedCondition DB="MedGen" ID="C2931875">Hermansky-Pudlak syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-14" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2022-02-13" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12442288</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16185271</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9497254</ID>
        </Citation>
        <DescriptionHistory Dated="2022-03-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6264" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2033" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hermansky-Pudlak syndrome</ElementValue>
                <XRef ID="Hermansky-Pudlak+syndrome/3391" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019312" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS203300" DB="OMIM" />
                <XRef ID="9311003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6643" />
                <XRef ID="6643" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.</Attribute>
                <XRef ID="NBK1287" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301464</ID>
                <ID Source="BookShelf">NBK1287</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="79430" DB="Orphanet" />
              <XRef ID="C0079504" DB="MedGen" />
              <XRef ID="MONDO:0019312" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS203300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1465" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10151" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DELTA STORAGE POOL DISEASE</ElementValue>
                <XRef Type="MIM" ID="203300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hermansky-Pudlak syndrome 1</ElementValue>
                <XRef ID="Hermansky-Pudlak+syndrome+1/8536" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008748" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPS1</ElementValue>
                <XRef Type="MIM" ID="203300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.</Attribute>
                <XRef ID="NBK1287" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18331" />
                <XRef ID="18331" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301464</ID>
                <ID Source="BookShelf">NBK1287</ID>
              </Citation>
              <XRef ID="231500" DB="Orphanet" />
              <XRef ID="79430" DB="Orphanet" />
              <XRef ID="C2931875" DB="MedGen" />
              <XRef ID="MONDO:0008748" DB="MONDO" />
              <XRef Type="MIM" ID="203300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4089082" SubmissionDate="2022-02-11" DateLastUpdated="2022-02-13" DateCreated="2022-02-13">
        <ClinVarSubmissionID localKey="390bbeb1-9c24-49c9-bacc-cd3a2850b439" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002097060" DateUpdated="2022-02-13" DateCreated="2022-02-13" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The p.Gly321fs variant in HPS1 has been reported in 1 individual, in the compound heterozygous state, with Hermansky-Pudlak syndrome (PMID: 9497254), and has been identified in 0.006% (1/15402) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs606231156). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. It is of note that this variant occurs in a homopolymer repeat, which could indicate that it exists as an artifact from sequencing. However, disease-causing variants have been reported in homopolymer regions, so this is not enough to rule out a pathogenic role. This variant has also been reported in ClinVar (Variation ID#: 21110) and has been interpreted as pathogenic by GeneReviews. This variant is predicted to cause a frameshift, which alters the proteinâ€™s amino acid sequence beginning at position 321 and leads to a premature termination codon 10 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the HPS1 gene is an established disease mechanism in autosomal recessive Hermansky-Pudlak syndrome. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive Hermansky-Pudlak syndrome. ACMG/AMP Criteria applied: PM3_supporting, PM2_supporting, PVS1 (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000195.5(HPS1):c.962del</Name>
            <Name>p.Gly321fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.11:g.98427245del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0019312" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11072064</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7849357" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000195.5:c.962del|OMIM:203300" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004199930" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000195.5:c.962del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="203300" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4245742" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4887247|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002228196" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12442288</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16185271</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9497254</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Gly321Alafs*10) in the HPS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HPS1 are known to be pathogenic (PMID: 12442288, 16185271). This variant is not present in population databases (ExAC no frequency). ClinVar contains an entry for this variant (Variation ID: 21110). This variant is also known as G321delG. This premature translational stop signal has been observed in individual(s) with Hermansky-Pudlak syndrome (PMID: 9497254).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.100186997del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7849357" TraitType="Disease" MappingType="XRef" MappingValue="203300" MappingRef="OMIM">
        <MedGen CUI="C2931875" Name="Hermansky-Pudlak syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4245742" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4089082" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0019312" MappingRef="MONDO">
        <MedGen CUI="C0079504" Name="Hermansky-Pudlak syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

